HTA evidence generation and preparedness for a novel oncology treatment

Less than 1 min read

Case study, HEOR Evidence Generation, Value, Pricing & Access

The challenge

Our client needed successful HTA evidence packages and submissions to achieve reimbursement across Europe for an innovative oncology treatment.

Our solution

We developed and implemented an HTA evidence generation strategy, including economic models, systematic literature reviews, statistical analyses, and expert engagement. We identified, obtained, and analyzed additional RWE data on patient quality of life to further support the evidence package.

The results

Our HTA team developed submissions for NICE and SMC, and provided support throughout the HTA processes, including representation at the HTA committees. Our HEOR experts also provided support on HTA processes, evidence requirements, and economic modeling to local affiliates, partnering with our client to successfully achieve access for patients to the new treatment across Europe.

Insights

More insights.

See all insights

Early oncology portfolio execution roadmap

We developed a forward-looking early development program evaluation tool that identifies key inflection points for early oncology portfolio.

Centers of Excellence

AI at Putnam

Open roles